🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to learn if loratadine can cont...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-12-14
Trial ID
NCT02392039
Treatments Being Tested
SB497115 is an oral agent which activates the thrombopoietin receptor and i...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04
Trial ID
NCT00110799
The study's main purpose is to asses the safety, tolerability, and effect o...
Status
Completed
Location
Arizona Retina and Vitreous Consultants
Start Date
2020-06-05
Trial ID
NCT04265261
The goal of this study is to evaluate the efficacy of HMPL-760 in combinati...
Status
Active Not Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2024-11-05
Trial ID
NCT06601504
The purpose of this study is to determine the benefit of relugolix 40 milli...
Status
Completed
Location
Birmingham
Start Date
2017-06-14
Trial ID
NCT03103087
To investigate efficacy and safety of Hydroxychloroquin in improving pregna...
Status
Unknown
Location
Multiple Locations
Start Date
2022-03-01
Trial ID
NCT05237843
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00703118
Treatments Being Tested
The purpose of this study was to evaluate dose response of the safety and e...
Status
Completed
Location
HealthStar Research, LLC
Start Date
2015-11-03
Trial ID
NCT02559570
Treatments Being Tested
The purpose of the study is to evaluate the effectiveness of two dosing reg...
Status
Completed
Location
Research Site
Start Date
2010-09
Trial ID
NCT01197534
Treatments Being Tested
This is a 24-week study investigating the safety and efficacy of several do...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-28
Trial ID
NCT00111800
Treatments Being Tested